Tumor Molecular Subtypes
Tumor Molecular Subtypes - Related Videos
14:40
Expression Analysis of Mammalian Linker-histone Subtypes
0 Views •
Cited by 22 •
2012
We describe a set of assays to analyze expression levels of H1 linker histones. mRNA of individual H1 genes are quantitatively measured by random primer based reverse transcription followed by real-time PCR, whereas protein quantification of H1 histones is achieved by HPLC analysis.
06:42
Subtype-selective Electroporation of Cortical Interneurons
0 Views •
Cited by 13 •
2014
This procedure shows how to target interneurons in the developing mouse forebrain by means of in utero electroporation. This technique was particularly efficient to achieve selective gene expression in interneuron subtypes destined to the superficial layers of the cortex.
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
0 Views •
Cited by 3 •
2013
To demonstrate MR cancer molecular imaging with a small peptide targeted MRI contrast agent specific to clotted plasma proteins in tumor stroma in a mouse prostate cancer model.
03:20
Identification of Mouse Retinal Ganglion Cell Subtypes Through Fluorescent Tracing
0 Views •
2025
Source: Laboissonniere, et. al. Single-cell RNA-Seq of Defined Subsets of Retinal Ganglion Cells. J. Vis. Exp. (2017). This video demonstrates a fluorescent tracing technique to identify retinal ganglion cell (RGC) subtypes in a transgenic mouse retina. The process involves securing the isolated retina in a recording chamber, maintaining cell viability with oxygenated perfusion, and targeting fluorescently labeled RGCs using a pipette with a tracer. By analyzing dendritic morphology and...
04:37
Three-Dimensional Quantitative Phase Imaging for Characterizing Lymphocyte Subtypes
0 Views •
2025
This video demonstrates label-free identification of lymphocyte morphology and biochemistry through 3D quantitative phase imaging. This technique allows for a thorough analysis of lymphocytes, uncovering their internal structures and properties without the need for labeling procedures.
FAQs
Tumor molecular subtypes are separated by combined molecular patterns, not by a single alteration. Relevant evidence can include DNA mutations, copy-number changes, gene-expression profiles, and epigenetic alterations. Considering these features together helps researchers distinguish tumors with different biological programs, including differences in how cells grow, persist, and respond to treatment.
In genetics, subtype analysis connects inherited or acquired molecular changes with tumor development and clinical behavior. This distinction provides context for interpreting why tumors may follow different biological or clinical courses. It also helps organize molecular findings into categories that can support prognosis and the search for treatment-relevant biomarkers.
Anatomical location does not fully capture the molecular processes that control tumor growth, survival, or treatment response. Consequently, tumors grouped by the same site can contain different molecular patterns and therefore show different clinical behavior. Subtyping adds a genetic and molecular layer that can improve prognostic interpretation beyond anatomy alone.
Gene-expression patterns help reveal which genes are active at different levels within a tumor. When interpreted alongside DNA mutations, copy-number changes, and epigenetic alterations, they provide a broader view of the molecular state associated with cell growth and survival. This combined perspective can distinguish biologically meaningful groups that might not be apparent from anatomy or one genetic measurement alone.
Researchers identify subtypes by examining several molecular data types rather than relying on one test. The source specifically highlights DNA mutations, copy-number changes, gene-expression profiles, and other molecular features, including epigenetic alterations. Comparing these patterns allows classification to reflect multiple layers of tumor biology and supports links between molecular findings, tumor behavior, and treatment response.
After subtype patterns are identified, researchers can use the classification to connect molecular findings with prognosis, biomarker-based therapy selection, and patient grouping in clinical studies. The assignment therefore serves as an interpretive step between molecular measurement and clinical research decisions. Its value depends on whether the subtype captures differences relevant to outcomes or treatment response.
These classifications can guide biomarker-based therapy selection by organizing patients according to molecular features linked to treatment response. They also support prognosis, allowing researchers to compare expected clinical behavior across groups. In clinical studies, subtype-based stratification can create biologically defined patient groups, making it easier to evaluate outcomes in relation to the molecular characteristics of their tumors.
In genetics research, subtype analysis is useful not only for sorting tumors but also for investigating how molecular alterations contribute to cancer. By revealing relationships among genetic, epigenetic, and expression features, it can point toward mechanisms for new diagnostic and therapeutic strategies. This makes subtype classification a bridge between molecular observation and hypothesis generation.